-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Neutral on Vera Therapeutics, Maintains $34 Price Target

Benzinga·08/17/2026 13:10:28
Listen to the news
Wedbush analyst Laura Chico reiterates Vera Therapeutics (NASDAQ:VERA) with a Neutral and maintains $34 price target.